Literature DB >> 1882813

Omeprazole therapy modifies the gastric localization of Helicobacter pylori.

S Vigneri, R Termini, A Scialabba, G Pisciotta, F Di Mario.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1882813

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

1.  Effect of specimen collection techniques, transport media, and incubation of cultures on the detection rate of Helicobacter pylori.

Authors:  R W van der Hulst; S B Verheul; J F Weel; Y Gerrits; F J ten Kate; J Dankert; G N Tytgat
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

Review 2.  A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy.

Authors:  U Peitz; A Hackelsberger; P Malfertheiner
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

Review 3.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

4.  Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole.

Authors:  R P Logan; M M Walker; J J Misiewicz; P A Gummett; Q N Karim; J H Baron
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

Review 5.  Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.

Authors:  M I Wilde; D McTavish
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

6.  Ranitidine Use and Gastric Cancer Among Persons with Helicobacter pylori.

Authors:  Shria Kumar; David S Goldberg; David E Kaplan
Journal:  Dig Dis Sci       Date:  2021-04-15       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.